Cognitive and Neural Hippocampal Effects of Long-Term Moderate Recurrent Hypoglycemia
- 1Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut
- 2Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut
- Address correspondence and reprint requests to Ewan C. McNay, Section of Endocrinology, Yale School of Medicine, One Gilbert Street, TAC S147, P.O. Box 208020, New Haven, CT 06519. E-mail: ewan.mcnay{at}yale.edu
Abstract
Recurrent hypoglycemia is the most feared complication of intensive insulin therapy for type 1 diabetes. Study of the cognitive impact of recurrent hypoglycemia in humans has been hampered by difficulty in controlling for prior glycemic history and diabetes status; there have been no prospective studies. We used a rat model of recurrent hypoglycemia with hypoglycemia for 3 h, once weekly, from 1 month of age. At 4, 8, and 12 months of age, cohorts were tested on a hippocampally dependent spatial memory task, during which hippocampal extracellular fluid (ECF) glucose and lactate were measured using microdialysis. At 4 months, recurrent hypoglycemia improved euglycemic task performance (76 ± 4 vs. 64 ± 3% for controls) and reversed the task-associated dip in ECF glucose seen in controls. However, recurrent hypoglycemia impaired performance in animals tested when hypoglycemic (45 ± 4 vs. 55 ± 2%). Recurrent hypoglycemia preserved euglycemic task performance across age: at 12 months, both task performance (62%) and ECF glucose changes in euglycemic recurrently hypoglycemic animals resembled those of 4-month-old control animals, whereas control animals’ performance deteriorated to chance (44%) by 8 months. At 12 months, hippocampal slice physiology was assessed, with results paralleling the cognitive findings: slices from recurrently hypoglycemic rats showed improved γ-aminobutyric acid (GABA)ergic inhibition at euglycemia but much greater loss of this tone at low bath glucose. Our data show that moderate weekly hypoglycemia prevented age-related decline in hippocampally cognitive function and cognitive metabolism, at least when euglycemic. The impact of recurrent hypoglycemia on cognition is multifaceted and includes both metabolic and electrophysiological components.
- aCSF, artificial cerebrospinal fluid
- ECF, extracellular fluid
- GABA, γ-aminobutyric acid
- PPI, paired pulse inhibition
Footnotes
-
- Accepted January 5, 2006.
- Received October 9, 2005.
- DIABETES














